Moreover, there was a significant co-expression of TFF3 with antiapoptotic proteins AKT1 (p = 0.0365), BCl2 (p = 0.0152), and NF Kappa-B (p = 0.0243) in breast carcinoma cases with residual carcinoma following neoadjuvant therapy, which reinforces the role of TFF3 in chemoresistance [62]. Here, TFF3 is linked to breast carcinoma.